Navigation Links
Auxogyn Announces Issuance of Key Patent Covering Predictive Embryo Assessment Parameters for In Vitro Fertilization
Date:6/27/2011

MENLO PARK, Calif., June 27, 2011 /PRNewswire/ -- Auxogyn, Inc., a privately held medical technology company focused on women's reproductive health, today announced that the U.S. Patent and Trademark Office (USPTO) issued patent number 7,963,906 covering three predictive parameters for the assessment of embryo viability during in vitro fertilization (IVF) procedures used in Auxogyn's early embryo viability assessment (Eeva™) System.

"This patent is the first to issue from a portfolio of patents filed related to our Eeva System in the United States, Europe and other countries," said Lissa Goldenstein, president and chief executive officer of Auxogyn. "We believe the value of our technology lies in the unique ability of our proprietary parameters to evaluate and predict, by day 2, the embryos that will continue development to blastocyst stage, which happens on day 5 of human development. By providing novel clinical data to IVF clinicians early, this non-invasive clinical tool has the potential to improve clinical pregnancy rates for IVF patients."

The Eeva System uses proprietary software to measure the three predictive parameters from time lapse video images of the embryos developing in a standard incubator and identify  on day 2 which embryos are most likely to continue development into blastocysts (day 5). Blastocyst formation is a critical milestone in human embryo development and provides objective criteria for selecting which embryo(s) to transfer. Use of the Eeva System is investigational, and the Eeva System has not been cleared by the U.S. Food and Drug Administration for commercial sale.

Auxogyn's proprietary non-invasive Eeva System is based on research of early human embryo development conducted at Stanford University and published in the October 2010 issue of Nature Biotechnology. The U.S. patent 7,963,906 was issued to Stanford University. Auxogyn has an exclusive license from Stanford University with wo
'/>"/>

SOURCE Auxogyn, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... to a survey by KLAS, an independent research firm, ... the number one ranking in the medical and/or radiology ... report. The survey of 247 customers of various vendors ... take a commanding lead over their competitors." MOSAIQ scored ... they would buy again and 96 percent confirmed that ...
(Date:10/25/2014)... Oct. 24, 2014 Research and Markets ... Market Current Trends, Opportunities - Global Forecast to 2019" ... this report, the global dental equipment market is categorized ... systems and equipment market is expected to register the ... the forecast period (2014 to 2019). This high growth ...
(Date:10/25/2014)... , Oct. 24, 2014 Advanced Photonix ® ... (ending September 26, 2014) financial results on Monday, November 10, ... released after the close of the market and the Company ... results at 4:30 p.m. EDT on the same day. ... (CEO and Director), Rob Risser (COO and ...
Breaking Medicine Technology:Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 2Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 3Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2
(Date:10/25/2014)... 26, 2014 LunaDress is excited to ... wedding dresses today. According to the company’s CEO, ... especially those dwelling in the UK. The company’s new ... They are all unpretentious and elegant. , These new ... inputs from top dress experts. LunaDress strives to provide ...
(Date:10/25/2014)... (PRWEB) October 26, 2014 Recently, ... best Joomla hosting suppliers of 2014. . According ... among the most excellent suppliers in the world. ... for webmasters to make money from hosting. The ... resources to host the others’ websites under a ...
(Date:10/25/2014)... Top 10 Best SEO Hosting is ... The site has recently compared many hosting companies and ... among the most reliable Linux web hosting companies in ... Best SEO Hosting says, “The hosting suppliers we recommend ... outperform their competitors on hosting features, uptime and server ...
(Date:10/25/2014)... 26, 2014 The past five ... Sugar Cane Growing industry in Australia . ... by extreme weather patterns, volatile commodity prices and ... industry analyst Brooke Tonkin, “Over the period, flooding ... of Australia's sugar cane crop.” Consequently, industry revenue ...
(Date:10/25/2014)... Diego, CA (PRWEB) October 25, 2014 ... synthetic biology, today announced Dr. Xun ... of all Research & Development. , Triton has developed ... high value algae-based proteins. According to Dr. Wang, the ... over traditional expression systems. He says, “Algae are unique ...
Breaking Medicine News(10 mins):Health News:LunaDress Now Release Its Designer Inspired Fashion Wedding Dresses For Customers Dwelling In The UK 2Health News:Top10BestSEOHosting.com: GoDaddy, Bluehost And Hostgator Are Among The Most Excellent Suppliers In The World 2Health News:Top 10 Best SEO Hosting Announces That GreenGeeks.com And HostMonster Are Among The Most Reliable Linux Web Hosting Companies In 2014 2Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3
... Cosmecueticals, beauty aids that reportedly work like prescription drugs, ... study recently published in the Journal of Cosmetic Dermatology ... provide a visibly noticeable improvement in maturing skin. , ... the lack of skin surface regularity, formation of wrinkles, ...
... 28 Versus,Technology, Inc. ("Versus" or the "Company") ... October 31, 2007, compared to,revenues of $2,177,000 for ... year,ended October 31, 2007, were $5,566,000 compared to ... vary significantly depending on,the timing and delivery of ...
... MB Software,Corporation (OTC Bulletin Board: MBSB) announced ... Equity Partners to issue 490.196 shares of its,Series ... cancellation of,approximately $1,500,000 in debt. The debt was ... affiliates. The preferred stock will,automatically convert into an ...
... gadolinium-containing contrast injections in adults and pediatric patients (those ... to a recent study conducted by researchers at the ... these reactions do occur, most of them are mild, ... study. , Over the past few years, the ...
... Dec. 28 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX,- ... for Drug Delivery,Platforms, announce that in order to ... directors, consultants and employees plan to,exercise stock options ... Lee, President and CEO, will cancel 6,000,000 options,granted ...
... 28 Lincare Holdings,Inc. (Nasdaq: LNCR ) today ... and Exchange Commission (the "SEC") a resale shelf registration,statement ... pursuant to the terms,of a registration rights agreement Lincare ... sale of its $275 million principal amount of,convertible senior ...
Cached Medicine News:Health News:Versus Technology Announces Fourth Quarter Results 2Health News:Versus Technology Announces Fourth Quarter Results 3Health News:Versus Technology Announces Fourth Quarter Results 4Health News:Versus Technology Announces Fourth Quarter Results 5Health News:Versus Technology Announces Fourth Quarter Results 6Health News:Versus Technology Announces Fourth Quarter Results 7Health News:MB Software Corporation Reaches Agreement with Keystone Equity Partners 2Health News:Allergic reactions to gadolinium-based contrast agents are rare, study finds 2Health News:AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares 2Health News:Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement 2
... including the Ceralas D and SmilePro 980 ... medical, dental, and veterinary environments.,With unsurpassed, optimal ... nm laser series allow controlled tissue ablation ... surgical procedures. Unlike other medical lasers, biolitecs ...
... Assay is a second generation nucleic acid ... in vitro qualitative detection and differentiation of ... uses a family of Gen-Probe's proven technologies ... and Dual Kinetic Assay (DKA). This is ...
... The InTray™ GC is a ... detection of both Neisseria gonorrhoeae and ... a long shelf life and is ... system. Simply inoculate, incubate and ...
... designed for patients with a spherical hyperopia between ... who would benefit from a spherical treatment of ... a myopic endpoint of between -1.00 D and ... improve near vision. CK is unique in that ...
Medicine Products: